Human MLH1(MutL Homolog 1) ELISA Kit
Contact us to Order: [email protected]
Human MLH1 (MutL Homolog 1) ELISA Kit |
MBS8803307-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1710 |
Human MLH1 (MutL Homolog 1) ELISA Kit |
MBS8803307-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 445 |
Human MutL Homolog 1 ELISA Kit (MLH1) |
RK01858 |
Abclonal |
96 Tests |
EUR 625.2 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
20-abx152407 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human MutL Homolog 1 (MLH1) ELISA Kit |
DLR-MLH1-Hu |
DL Develop |
96T |
EUR 463 |
|
Description: tissue homogenates, cell lysates or other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
DLR-MLH1-Hu-48T |
DL Develop |
48T |
EUR 620.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human MutL Homolog 1 (MLH1) in samples from tissue homogenates, cell lysates or other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
DLR-MLH1-Hu-96T |
DL Develop |
96T |
EUR 807.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human MutL Homolog 1 (MLH1) in samples from tissue homogenates, cell lysates or other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
DL-MLH1-Hu |
DL Develop |
96T |
EUR 441 |
|
Description: tissue homogenates, cell lysates or other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
EK15463 |
SAB |
96Т |
EUR 768 |
|
Human MutL Homolog 1 (MLH1) ELISA Kit |
RDR-MLH1-Hu-48T |
Reddot Biotech |
48T |
EUR 475.34 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RDR-MLH1-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 652.8 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RDR-MLH1-Hu-96T |
Reddot Biotech |
96T |
EUR 679.04 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RDR-MLH1-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 907.2 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RD-MLH1-Hu-48T |
Reddot Biotech |
48T |
EUR 452.7 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RD-MLH1-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 625.2 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RD-MLH1-Hu-96T |
Reddot Biotech |
96T |
EUR 646.7 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
RD-MLH1-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 867.6 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
SEJ742Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5677.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
SEJ742Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 572.76 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
SEJ742Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 766.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
SEJ742Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3090.6 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
4-SEJ742Hu |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human MutL Homolog 1 (MLH1) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2022593-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5320 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2022593-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 360 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2022593-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 545 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2022593-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2915 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2022593-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 720 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS4501050-10x96Tests |
MyBiosource |
10x96Tests |
EUR 5260 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS4501050-48Tests |
MyBiosource |
48Tests |
EUR 460 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS4501050-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2700 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS4501050-96Test |
MyBiosource |
96Test |
EUR 605 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2706758-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3130 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2706758-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 255 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2706758-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 330 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2706758-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1630 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS2706758-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 420 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS452937-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5050 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS452937-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 440 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS452937-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2590 |
Human MutL Homolog 1 (MLH1) ELISA Kit |
MBS452937-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 585 |
ELISA kit for Human MLH1 (MutL Homolog 1) |
ELK4307 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of MutL Homolog 1 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Human MutL Homolog 1 (MLH1) CLIA Kit |
20-abx495774 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
ELISA Kit for MutL Homolog 1 (MLH1) |
SEJ742Hu |
Cloud-Clone |
96Т |
EUR 700 |
|
Rat MutL Homolog 1 (MLH1) ELISA Kit |
abx533185-96tests |
Abbexa |
96 tests |
EUR 687.5 |
Plant MutL Homolog 1 (MLH1) ELISA Kit |
MBS9380661-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
MLH1 (MutL Homolog 1) |
MO47010 |
Neuromics |
100 ul |
EUR 418.8 |
MLH1 (MutL Homolog 1) |
MBS4381087-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
MLH1 (MutL Homolog 1) |
MBS4381087-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
MLH1 (MutL Homolog 1) |
MBS4381087-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
MLH1 (MutL Homolog 1) |
MBS4381087-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
MLH1 (MutL Homolog 1) |
MBS4381087-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
MLH1 (MutL Homolog 1) |
MBS556109-01mL |
MyBiosource |
0.1mL |
EUR 455 |
MLH1 (MutL Homolog 1) |
MBS556109-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1895 |
Human MutL Homolog 1 (MLH1) Protein |
20-abx654421 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human MutL Homolog 1 (MLH1) Protein |
abx654421-20g |
Abbexa |
20 µg |
EUR 337.5 |
Human MutL Homolog 1 (MLH1) Protein |
abx654421-5g |
Abbexa |
5 µg |
EUR 200 |
MLH1 (MutL Homolog 1)(MLH1/1324), 0.2mg/mL |
BNUB1324-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), 0.2mg/mL |
BNUB1324-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), 1mg/mL |
BNUM1324-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MutL Homolog 1 (MLH1) Antibody |
20-abx113897 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx002899 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
abx012221-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
MutL Homolog 1 (MLH1) Antibody |
abx025515-100ul |
Abbexa |
100 ul |
EUR 627.6 |
|
MutL Homolog 1 (MLH1) Antibody |
abx026385-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
MutL Homolog 1 (MLH1) Antibody |
abx026385-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
MutL Homolog 1 (MLH1) Antibody |
20-abx008989 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx014046 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 200 ug
- 20 ug
- 300 µg
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx000639 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
MutL Homolog 1 (MLH1) Antibody |
abx235213-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
MutL Homolog 1 (MLH1) Antibody |
20-abx173641 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx177638 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx328114 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx241566 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx241567 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
MutL Homolog 1 (MLH1) Antibody |
20-abx317973 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
MutL Homolog 1 (MLH1) Antibody |
abx113897-100l |
Abbexa |
100 µl |
EUR 612.5 |
MutL Homolog 1 (MLH1) Antibody |
abx026385-400l |
Abbexa |
400 µl |
EUR 518.75 |
MutL Homolog 1 (MLH1) Antibody |
abx025515-400l |
Abbexa |
400 µl |
Ask for price |
MutL Homolog 1 (MLH1) Antibody |
abx025515-80l |
Abbexa |
80 µl |
EUR 518.75 |
MutL Homolog 1 (MLH1) Antibody |
abx235213-100g |
Abbexa |
100 µg |
EUR 350 |
MutL Homolog 1 (MLH1) Antibody |
abx241566-96tests |
Abbexa |
96 tests |
EUR 250 |
MutL Homolog 1 (MLH1) Antibody |
abx241567-96tests |
Abbexa |
96 tests |
EUR 250 |
MutL Homolog 1 (MLH1) Antibody |
abx328114-100g |
Abbexa |
100 µg |
EUR 250 |
MutL Homolog 1 (MLH1) Antibody |
abx328114-50g |
Abbexa |
50 µg |
EUR 187.5 |
MutL Homolog 1 (MLH1) Antibody |
abx317973-100g |
Abbexa |
100 µg |
EUR 362.5 |
MutL Homolog 1 (MLH1) Antibody |
abx317973-20g |
Abbexa |
20 µg |
EUR 162.5 |
MutL Homolog 1 (MLH1) Antibody |
abx317973-50g |
Abbexa |
50 µg |
EUR 250 |
MutL Homolog 1 (MLH1) Antibody |
abx014046-100l |
Abbexa |
100 µl |
EUR 43.75 |
MutL Homolog 1 (MLH1) Antibody |
abx012221-100g |
Abbexa |
100 µg |
Ask for price |
MutL Homolog 1 (MLH1) Antibody |
abx012221-10g |
Abbexa |
10 µg |
EUR 362.5 |
MutL Homolog 1 (MLH1) Antibody |
abx012221-200g |
Abbexa |
200 µg |
Ask for price |
MutL Homolog 1 (MLH1) Antibody |
abx000639-100l |
Abbexa |
100 µl |
EUR 387.5 |
MutL Homolog 1 (MLH1) Antibody |
abx000639-20l |
Abbexa |
20 µl |
EUR 175 |
MutL Homolog 1 (MLH1) Antibody |
abx000639-50l |
Abbexa |
50 µl |
EUR 275 |
MLH1 Antibody / MutL Homolog 1 |
V8749-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V8749-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V8749SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V9166-100UG |
NSJ Bioreagents |
100ug |
EUR 424.15 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V9166-20UG |
NSJ Bioreagents |
20ug |
EUR 186.15 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V9166SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 424.15 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4038-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4038-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4038SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V9349-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V9349-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V9349SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4970-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4970-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4970SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4971-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4971-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4971SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4972-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4972-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4972SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4973-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4973-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4973SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4974-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4974-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
MLH1 Antibody / MutL Homolog 1 |
V4974SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: This mAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
Recombinant MutL Homolog 1 (MLH1) |
RPJ742Hu01 |
Cloud-Clone |
10ug |
EUR 140 |
Recombinant MutL Homolog 1 (MLH1) |
RPJ742Hu02 |
Cloud-Clone |
10ug |
EUR 143 |
Recombinant MutL Homolog 1 (MLH1) |
RPJ742Hu03 |
Cloud-Clone |
10ug |
EUR 144 |
Recombinant MutL Homolog 1 (MLH1) |
MBS2139860-001mg |
MyBiosource |
0.01mg |
EUR 155 |
Recombinant MutL Homolog 1 (MLH1) |
MBS2139860-005mg |
MyBiosource |
0.05mg |
EUR 260 |
Recombinant MutL Homolog 1 (MLH1) |
MBS2139860-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Recombinant MutL Homolog 1 (MLH1) |
MBS2139860-02mg |
MyBiosource |
0.2mg |
EUR 460 |
Recombinant MutL Homolog 1 (MLH1) |
MBS2139860-05mg |
MyBiosource |
0.5mg |
EUR 860 |
Human MLH3(MutL Homolog 3) ELISA Kit |
ELK7522-48T |
ELK Biotech |
48T |
Ask for price |
|
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MLH3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MLH3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MLH3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MLH3 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human MLH3(MutL Homolog 3) ELISA Kit |
ELK7522-96T |
ELK Biotech |
96T |
Ask for price |
|
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MLH3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MLH3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MLH3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MLH3 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human MLH3 (MutL Homolog 3) ELISA Kit |
MBS8806499-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3130 |
Human MLH3 (MutL Homolog 3) ELISA Kit |
MBS8806499-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 350 |
Human MLH3 (MutL Homolog 3) ELISA Kit |
MBS8806499-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1710 |
Human MLH3 (MutL Homolog 3) ELISA Kit |
MBS8806499-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 445 |
MutL Homolog 1 (MLH1) Antibody (HRP) |
20-abx313263 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
MutL Homolog 1 (MLH1) Antibody (HRP) |
abx313263-100g |
Abbexa |
100 µg |
EUR 362.5 |
MutL Homolog 1 (MLH1) Antibody (HRP) |
abx313263-20g |
Abbexa |
20 µg |
EUR 162.5 |
MutL Homolog 1 (MLH1) Antibody (HRP) |
abx313263-50g |
Abbexa |
50 µg |
EUR 250 |
MutL Homolog 1 (MLH1) Antibody (FITC) |
20-abx313264 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
MutL Homolog 1 (MLH1) Antibody (FITC) |
abx313264-100g |
Abbexa |
100 µg |
EUR 362.5 |
MutL Homolog 1 (MLH1) Antibody (FITC) |
abx313264-20g |
Abbexa |
20 µg |
EUR 162.5 |
MutL Homolog 1 (MLH1) Antibody (FITC) |
abx313264-50g |
Abbexa |
50 µg |
EUR 250 |
MutL Homolog 1 (MLH1) Antibody (Biotin) |
20-abx313265 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
MutL Homolog 1 (MLH1) Antibody (Biotin) |
abx313265-100g |
Abbexa |
100 µg |
EUR 362.5 |
MutL Homolog 1 (MLH1) Antibody (Biotin) |
abx313265-20g |
Abbexa |
20 µg |
EUR 162.5 |
MutL Homolog 1 (MLH1) Antibody (Biotin) |
abx313265-50g |
Abbexa |
50 µg |
EUR 250 |
MLH1 (MutL Homolog 1)(MLH1/1324), CF594 conjugate, 0.1mg/mL |
BNC941324-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF594 conjugate, 0.1mg/mL |
BNC941324-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF647 conjugate, 0.1mg/mL |
BNC471324-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF647 conjugate, 0.1mg/mL |
BNC471324-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF568 conjugate, 0.1mg/mL |
BNC681324-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF568 conjugate, 0.1mg/mL |
BNC681324-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF405S conjugate, 0.1mg/mL |
BNC041324-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF405S conjugate, 0.1mg/mL |
BNC041324-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MLH1 (MutL Homolog 1)(MLH1/1324), CF488A conjugate, 0.1mg/mL |
BNC881324-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Human MLH1(MutL Homolog 1) ELISA Kit